News | April 27, 2026
Raay Neo Pharma launches operations to expand access to quality healthcare across India
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Muted movement reflects consolidation phase as investors await earnings triggers
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Subscribe To Our Newsletter & Stay Updated
